Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Altshuler David
Relationship:   EVP, Chief Scientific...
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   25,813    

Indirect Shares

   0      
Direct Value   $12,136,756    

Indirect Value

   $0      
Total Shares   25,813      
Total Value   $12,136,756      


Vertex Pharmaceuticals Inc $12,136,756 Vertex Pharmaceuticals Inc $12,136,756
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, Chief Scientific... 2024-05-15 25,813 2014-07-31 0    Premium*  
* Premium Members only  

Records found :    157         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2019-08-19 4 AS $186.37 $2,329,976 D/D (12,501) 31,553 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2019-10-22 4 AS $194.37 $713,144 D/D (3,669) 31,553 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2019-11-04 4 AS $200.26 $827,049 D/D (4,126) 31,553 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2019-11-06 4 AS $196.08 $241,189 D/D (1,223) 31,553 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2019-11-15 4 AS $205.95 $12,357 D/D (60) 31,553 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2019-11-25 4 AS $219.37 $857,737 D/D (3,910) 31,553 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-02-03 4 AS $229.35 $953,861 D/D (4,126) 31,553 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-02-06 4 AS $238.74 $604,775 D/D (2,526) 70,310 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-02-11 4 AS $243.36 $4,191,771 D/D (17,032) 39,970 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-02-18 4 AS $241.80 $762,201 D/D (3,128) 34,346 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-02-25 4 AS $229.72 $706,776 D/D (3,028) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-05-04 4 AS $259.18 $607,803 D/D (2,330) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-05-06 4 AS $270.20 $333,195 D/D (1,222) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-05-12 4 AS $287.33 $374,678 D/D (1,304) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-05-15 4 AS $274.98 $23,318 D/D (82) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-08-03 4 AS $276.84 $648,290 D/D (2,330) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-08-06 4 AS $270.12 $331,663 D/D (1,223) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2020-11-16 4 AS $222.45 $8,492 D/D (38) 28,902 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2021-02-11 4 AS $210.42 $1,112,274 D/D (5,283) 53,098 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2021-02-18 4 AS $210.11 $1,657,590 D/D (7,825) 39,033 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2021-02-25 4 AS $211.58 $646,139 D/D (3,028) 33,589 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2021-05-17 4 AS $215.31 $17,093 D/D (79) 33,589 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2021-11-15 4 AS $186.80 $6,365 D/D (34) 33,589 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2022-02-02 4 AS $247.73 $1,171,842 D/D (4,660) 65,697 0 %
VRTX Vertex Pharmaceuticals In... EVP, Global Research and CSO   •       –      –    2022-02-11 4 AS $233.92 $539,837 D/D (2,297) 59,882 0 %
  157  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us